H.F. Kühnle - Concepedia

Author

H.F. Kühnle

Roche (United States)

Also Known As

H F Kühnle, H Kühnle, H. F. Kühnle, H. Kühnle, H.F. Kuhnle, H.F. KÜhnle, H.F. Kühnle, Hans-Frieder Kühnle

Publications

295

Citations

H-Index

Concepts

All Affiliations

Roche (United States)Heidelberg University Roche Pharma AG (Germany)

About

H.F. Kühnle is an author at Roche (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	219
2	Biochemistry	5	5	195
3	Health Sciences	3	3	54
4	Natural Sciences	2	2	125
5	Chemical Biology	1	1	114

H.F. Kühnle

Publications

267

Citations

H-Index

Page 1

	Year	Citations
Determination of phosphoenolpyruvate carboxykinase activity with deoxyguanosine 5′-diphosphate as nucleotide substrate Ioan Petrescu, O. Bojan, M. Saied, Analytical Biochemistry BiosynthesisCellular EnzymologyBiochemistryBioenergeticsNatural Sciences	1979	114
Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism Clemens Fürnsinn, Barbara Brunmair, M.E. Meyer, British Journal of Pharmacology	1999	32
Species differences in induction of hepatic enzymes by BM 17.0744, an activator of peroxisome proliferator-activated receptor alpha (PPARα) Kirstin Meyer, Alfred Völkl, R. Endele, Archives of Toxicology Molecular PhysiologyHepatologyBiochemistryMedicineLiver Physiology	1999	30
BM 17.0744: A structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity Johannes Pill, H.F. Kühnle Metabolism Pharmaceutical ScienceBiochemistryMedicineInsulin ManagementDiabetes	1999	27
Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs. G. Sponer, H.F. Kühnle, K. Strein, Journal of Pharmacology and Experimental Therapeutics	1984	16
Studies on the mechanism of action of the hypoglycemic agent, 2-(3-methylcinnamylhydraznoo)-propionate (BM 42.304) Ion V. Deaciuc, H.F. Kühnle, Kim Strauss, Biochemical Pharmacology BiochemistryMedicinePhysiologyMechanism Of ActionHypoglycemic Agent	1983	13
Effect of the new oral antidiabetic agent (−)-BM 13.0913.Na on insulin resistance in lean and obese zucker rats Rolf Apweiler, H.F. Kühnle, Gerd Ritter, Metabolism ObesityMetabolic SyndromeInsulin ResistanceDiabetes ManagementMedicine	1995	12
(−)-BM 13.0913: A new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non—insulin-dependent) diabetes mellitus Peter R. Freund, H. P. Wolff, H.F. Kühnle Metabolism Insulin ResistanceMetabolic SyndromeInsulin SensitivityDiabetes ManagementMedicine	1995	12
ω-Substituted alkyl carboxylic acids as antidiabetic and lipid-lowering agents Kirstin Meyer, Richard Neidlein, H.F. Kühnle, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesDiabetes	1998	11

Page 1